METTL3 and hepatocellular carcinoma: In conclusion, Tan-IIA suppressed METTL3-mediated m6A modification of TRIB3 mRNA, resulting in the repression of HCC cell proliferation, invasion, and stemness, providing a new theoretical basis to support Tan-IIA as a drug against HCC.